Get startedLog in
    Picture of Sensorion SA logo

    ALSEN — Sensorion SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Sensorion Initiates Safety Study Of Seliforant Vs Meclizine In Evoked Vestibular Imbalance

    Picture of Sensorion SA logoSensorion SA
    24/07/2018 13:29
    July 24 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION INITIATES SAFETY STUDY OF SELIFORANT VERSUS
MECLIZINE
IN EVOKED VESTIBULAR IMBALANCE
    * ANNOUNCED INITIATION OF PATIENT ENROLLMENT IN A PHASE 2A
STUDY
(SENS-111-202) TO CONFIRM ABSENCE OF ANTICHOLINERGIC SIDE
EFFECTS WITH MECLIZINE DURING AN EVOKED VESTIBULAR IMBALANCE

Source text for Eikon:  urn:newsml:reuters.com:*:nGNXb799sp
Further company coverage:  ALSEN.PA 

 (Reporting by Akanksha Rana)
 ((Akanksha.Rana@thomsonreuters.com;))

    Recent news on Sensorion SA

    See all news